Maven Securities’s ADMA Biologics ADMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-35,000
Closed -$513K 461
2025
Q3
$513K Buy
+35,000
New +$600K 0.1% 409
2024
Q2
Sell
-50,000
Closed -$330K 901
2024
Q1
$330K Buy
+50,000
New +$273K 0.02% 264
2023
Q2
Sell
-50,000
Closed -$166K 848
2023
Q1
$166K Buy
+50,000
New +$173K 0.03% 889
2022
Q4
Sell
-15,000
Closed -$37K 817
2022
Q3
$37K Sell
15,000
-454,206
-97% -$1.09M ﹤0.01% 1077
2022
Q2
$929K Sell
469,206
-3,022,318
-87% -$5.95M 0.16% 388
2022
Q1
$6.39M Buy
3,491,524
+175,917
+5% +$274K 1.32% 67
2021
Q4
$4.67M Buy
+3,315,607
New +$4.36M 0.58% 94
2021
Q2
Sell
-750,325
Closed -$1.32M 1022
2021
Q1
$1.32M Buy
+750,325
New +$1.72M 0.12% 316

Other funds holding ADMA